This wiki has undergone a migration to Confluence found Here
Difference between revisions of "20130508 HL7 PLA Meeting"
Jump to navigation
Jump to search
| Line 40: | Line 40: | ||
**May need to develop a form to describe and propose a product line from an existing set of products. | **May need to develop a form to describe and propose a product line from an existing set of products. | ||
**With establishment of a product family we need some assignment of governance, management, and methodology with SAIF-CD precepts. | **With establishment of a product family we need some assignment of governance, management, and methodology with SAIF-CD precepts. | ||
| + | **S&I Framework might have held interest for U.S. Affiliate but has lost financial support. only 90 international attendees would not support separation of an U.S. Affiliate. | ||
| + | |||
| + | *further analysis of product line development will be conducted in Q4 with SAIF AP review of the Cross-paradigm immunization project. | ||
Revision as of 18:24, 8 May 2013
Contents
HL7 Product Line Architecture – 2013-01-15 Meeting
Return to HL7 Product Line Architecture Wiki Home Page<br\> Return to HL7 Product Line Architecture Meeting Minutes and Agendas
Attendees: Austin, Rick Haddorff, Lynn
Meeting Logistics
- Dates: Wednesday Q3 of the Working Group Meeting
- Time: 13:45 - 15:00 Eastern Time
- Room: Georgia 7
Q3 Agenda for HL7 Product Line Architecture
- Roll Call
- Agenda Review
- BAM Overview (15 min) (Parker)
- BAM landing - review scope document.
- Identify candidates for Product Families and Product Lines (so far we have FHIR)
- How to take an existing set of products and make it into a Product Family/Product Line (e.g. CDA)
- Next WGM Needs
Minutes
- Ron is not available - they are not as far along as they thought they would be on the BAM
- We're not ready to offer sufficient guidance to SDWG in standing up CDA IGs as product family
- ArB is re-evaluating product family/line definition or approach
- Product Family candidate suggestions based on methodologies and how they are produced.
- V2
- V2.x IG
- Arden Syntax
- EHR FPs
- EHR
- V3
- CDA IGs
- SOA
- Current focus is on product family and not devoted to definition of product lines at this time.
- Cross-paradigm project done by Alean is an excellent example of analysis for product line across interoperability paradigms.
- Austin sees a product line forming around the CCDA effort with CCDA-related products including the base CCDA itself. They have related use cases, and foundation of the CCDA header and the U.S. market segment.
- Other Meaningful Use product line requirements are forming around V2 IGs such as LRI, LOI, ELR-PH, eDOS set of products. CDS MU support may be included with Infobutton. QRDA, eMeasure, HQMF evolving.
- May need to develop a form to describe and propose a product line from an existing set of products.
- With establishment of a product family we need some assignment of governance, management, and methodology with SAIF-CD precepts.
- S&I Framework might have held interest for U.S. Affiliate but has lost financial support. only 90 international attendees would not support separation of an U.S. Affiliate.
- further analysis of product line development will be conducted in Q4 with SAIF AP review of the Cross-paradigm immunization project.
